Sironax
We are seeking a proactive and highly motivated Animal Experimentation Senior Scientist / Scientist to support in vivo pharmacology and PK/PD studies across our drug discovery pipeline. The successful candidate will possess strong hands-on experience in rodent studies and be able to independently perform dosing, sample collection, tissue harvesting, and data analysis. This role requires close collaboration with cross-functional teams to ensure the efficient execution of research projects.
Sironax is a biopharmaceutical company committed to developing transformative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseases. The company targets underlying contributors of aging and degeneration — including disrupted energy homeostasis, dysregulated cell death, and uncontrolled inflammation — across various organs and tissues. Its pipeline includes first-in-class and best-in-class small molecule and large molecule programs, with clinical-stage assets such as a SARM1 inhibitor and a NAMPT activator.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sironax.
Sironax didn’t post a salary, so this is our estimate from similar listings.